Methods of detection of circulating melanoma cells: a comparative overview
- PMID: 21106295
- DOI: 10.1016/j.ctrv.2010.10.002
Methods of detection of circulating melanoma cells: a comparative overview
Abstract
Disease dissemination is the major cause of melanoma-related death. A crucial step in the metastatic process is the intravascular invasion and circulation of melanoma cells in the bloodstream with subsequent development of distant micrometastases that is initially clinically undetectable and will eventually progress into clinically apparent metastasis. Therefore, the use of molecular methods to detect circulating melanoma cells may be of value in risk stratification and clinical management of such patients. Herein, we review the currently applied techniques for the detection, isolation, enrichment and further characterization of circulating melanoma cells from peripheral blood samples in melanoma patients. Furthermore, we provide a brief overview of the various molecular markers currently being evaluated as prognostic indicators of melanoma progression.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.Melanoma Res. 2007 Apr;17(2):75-82. doi: 10.1097/CMR.0b013e328054c667. Melanoma Res. 2007. PMID: 17496782
-
Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.Melanoma Res. 2007 Apr;17(2):83-9. doi: 10.1097/CMR.0b013e3280a60878. Melanoma Res. 2007. PMID: 17496783
-
[Current biological markers of cutaneous melanoma progression].Ann Biol Clin (Paris). 2000 Mar-Apr;58(2):157-65. Ann Biol Clin (Paris). 2000. PMID: 10760702 Review. French.
-
Detection of occult melanoma cells in sentinel lymph nodes and blood.Semin Oncol. 1997 Feb;24(1 Suppl 4):S11-5. Semin Oncol. 1997. PMID: 9122728 Review.
-
Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.Clin Cancer Res. 1999 May;5(5):1099-105. Clin Cancer Res. 1999. PMID: 10353744
Cited by
-
Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.Mol Diagn Ther. 2014 Apr;18(2):175-83. doi: 10.1007/s40291-013-0071-2. Mol Diagn Ther. 2014. PMID: 24297151 Free PMC article. Review.
-
Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis.BMC Cancer. 2011 Aug 4;11:336. doi: 10.1186/1471-2407-11-336. BMC Cancer. 2011. PMID: 21816094 Free PMC article.
-
Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma.Target Oncol. 2014 Mar;9(1):63-71. doi: 10.1007/s11523-013-0276-7. Epub 2013 Apr 23. Target Oncol. 2014. PMID: 23609056
-
S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells.Cells. 2019 Jul 20;8(7):755. doi: 10.3390/cells8070755. Cells. 2019. PMID: 31330795 Free PMC article.
-
Capture and On-chip analysis of Melanoma Cells Using Tunable Surface Shear forces.Sci Rep. 2016 Jan 27;6:19709. doi: 10.1038/srep19709. Sci Rep. 2016. PMID: 26815318 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical